These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 360366)

  • 21. Ancrod in the treatment of acute ischaemic stroke.
    Atkinson RP
    Drugs; 1997; 54 Suppl 3():100-8. PubMed ID: 9360857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin perfusion pressure of the foot is a good substitute for toe pressure in the assessment of limb ischemia.
    Tsai FW; Tulsyan N; Jones DN; Abdel-Al N; Castronuovo JJ; Carter SA
    J Vasc Surg; 2000 Jul; 32(1):32-6. PubMed ID: 10876204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of non-invasive techniques for the assessment of critical limb ischaemia.
    Ubbink DT; Tulevski II; den Hartog D; Koelemay MJ; Legemate DA; Jacobs MJ
    Eur J Vasc Endovasc Surg; 1997 Mar; 13(3):296-300. PubMed ID: 9129603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
    Heidrich H
    Med Klin; 1978 May; 73(21):798-800. PubMed ID: 651769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
    Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
    Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ancrod improves survival in murine systemic lupus erythematosus.
    Cole EH; Glynn MF; Laskin CA; Sweet J; Mason N; Levy GA
    Kidney Int; 1990 Jan; 37(1):29-35. PubMed ID: 2299806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ancrod.
    Sherman DG
    Curr Med Res Opin; 2002; 18 Suppl 2():s48-52. PubMed ID: 12365829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ancrod causes rapid thrombolysis in patients with acute stroke.
    Pollak VE; Glas-Greenwalt P; Olinger CP; Wadhwa NK; Myre SA
    Am J Med Sci; 1990 May; 299(5):319-25. PubMed ID: 2186630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of defibrination on tumor growth and response to chemotherapy.
    DeWys WD; Kwaan HC; Bathina S
    Cancer Res; 1976 Oct; 36(10):3584-7. PubMed ID: 953985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Falsely elevated ankle pressures in severe leg ischaemia: the pole test--an alternative approach.
    Smith FC; Shearman CP; Simms MH; Gwynn BR
    Eur J Vasc Surg; 1994 Jul; 8(4):408-12. PubMed ID: 8088390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of enzymatic blood defibrination in subcortical arteriosclerotic encephalopathy.
    Ringelstein EB; Mauckner A; Schneider R; Sturm W; Doering W; Wolf S; Maurin N; Willmes K; Schlenker M; Brückmann H
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1051-7. PubMed ID: 3063776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative estimation of run off in patients with multiple level arterial obstructions as a guide to partial reconstructive surgery.
    Noer I; Tønnesen KH; Sager P
    Ann Surg; 1978 Nov; 188(5):663-5. PubMed ID: 718291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgery.
    Belch JJ; Meek DR; Lowe GD; Campbell AF; Young AB; Forbes CD; Prentice CR
    Thromb Res; 1982 Jan 1-15; 25(1-2):23-31. PubMed ID: 7038977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial.
    Telles GS; Campbell WB; Wood RF; Collin J; Baird RN; Morris PJ
    Br J Surg; 1984 Jul; 71(7):506-8. PubMed ID: 6375799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defibrination with ancrod in nephrotoxic nephritis in rabbits.
    Thomson NM; Moran J; Simpson IJ; Peters DK
    Kidney Int; 1976 Nov; 10(5):343-7. PubMed ID: 794557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor.
    Dosekun AK; First MR; Chandran PK; Kant KS; Glas-Greenwalt P; Weiss MA; Alexander JW; Pollak VE
    Clin Nephrol; 1982 Aug; 18(2):101-5. PubMed ID: 6754189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of defibrination with ancrod in experimental allergic glomerular injury.
    Naish PF; Evans DJ; Peters DK
    Clin Exp Immunol; 1975 May; 20(2):303-9. PubMed ID: 1212811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled trial of ancrod in ischemic stroke.
    Hossmann V; Heiss WD; Bewermeyer H; Wiedemann G
    Arch Neurol; 1983 Dec; 40(13):803-8. PubMed ID: 6196006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.